Summer 2000 Vol.12,No.2 Date

Total Page:16

File Type:pdf, Size:1020Kb

Summer 2000 Vol.12,No.2 Date The Newsletter of the NIH Alumni Association Summer 2000 Vol.12,No.2 date NIHAA Members Enjoy Annual Meeting with Osborn, Kirschstein, and Spiegel "The health of the NIH is good." Dr. Ruth Kirscbstein, acting NIH director, told NIH alumni as she summarized the history and future prospects of the agency at the annual meeting of the NIH Alumni Association. Kirschstein's presentation was the first of three highlights of the well-attended member­ ship meeting on June 17,2000. NTI-lAA Public ServiceAwardee Dr. fane E. Osborn spoke of her experiences as a scientific advisor and reviewer for NIH, and Dr. Allen M. Spiegel, NIDDK director. traced N1H intramural research on signal transduction over a 30-year period. Dr. William Gay, tbe NIRAA president who opened and presided over the Dr. William I. Gay presents the 8th NIHAA Public Service Award to Dr. June E. Osborn during session beld at the Mary Woodard the group's annual meeting, held June 17 at the Mary Woodard Lasker Center (the Cloister) Lasker Center, announced the election on the NIH campus. (See Annual Meeting, p. 12) Shalala Speaks Frankly at BOth ACD Meeting In This Issue Page Angell To Give Fourth Research Festival '00 3 By Rich M cManus NIHAA Shannon Lecture Ca/1111dar ofexhibits anti e11e111s 5 HHS Secretary Donna Shalala Dr. Marcia Angell. fo1mer editor-in­ dropped in on the 80'h meeting of the News from and abour NIHAA members 6 chief of the New England l oumal of advisory committee to the NIH director Update 011 two Nobel laureates I 0 Medicine, will deliver tbe founh James on June 8 Lo offer encouragement and A. Shannon Lecture on Feb. 14, 200 l at congratulations on a variety of topics NlHAA members tour NIH 1 3 3 p.m. in Masur Auditorium, Bldg. 10. including the FY 2001 budget, NIH's She will speak on, "Tbe Ethics of Missing from rhe stacks 15 effort to bo.lster oversight of human Clinical Trials.'' The Shannon Lecture gene transfer, the progress of the Working draft of h11ma11 is sponsored by NlHAA. Human Genome Project, and NlH's genome a111101111ced 16 Angell. who is a lecturer in social initiative to reduce health disparities. medicine at Harvard Medical School, Health dispariries top NIH agenda 18 She also expanded upon and ap­ bas been associated with the New plauded President Clinton's decision, FNlH rack/es family lodge project 20 England Joumal ofMedicine for over announced that morning, to extend two decades. She joined the Jo11rnal in Medicare coverage to participants in FYI 22 1979 and became executive editor in clinical trials, and answered questions NIH notes 24 1988. In September 1999. she became in a relaxed and freewheeling session. interim editor-in-chief following the "You've bad me as candid as I've ever NIH retrospectives 31 departure ofDr. Jerome P. Kassirer. (See ACD Meeting, p. 14) (See Angell, p. 2) N I H A A U P D A T E Angell (continued from p. I) She is a board-certified pathologist In 1997, the NIHAA established a who received her M.D. from Boston lecture seri es named to honor Dr. James Update University School of Medicine., and A. Shannon, NIH director from 1955 to trained in internal medicine at Mt. 1968, a period of considerable growth Auburn and University Hospitals and and redirection for the institutes. The NIHAA Update is the nell'slerrer of the in pathology at Mt. Auburn and New The first lecrure was given by Dr. NJHA/wnni Association. The NlflAA office is England Deaconess Hospitals. Joseph Goldstein in January 1997 and at 9101 Old Georgetown Rd., Bethesda, MD Known, both nationall y and interna­ 20814-1522, 301-530-0567; email address: subsequently published (with Dr. [email protected]: website: www.fnih. tionally, for her writings on medical Michael S. Brown) in the Journal of orglnih.111111. ethics and health policy, she is the Clinical Investigation, 99:2803-2812 author of lhe book Science on Trial: under lhe title "T11e clinical investigator: Editor's Note The Clash of Medical Evidence and bewitched, bothered and bewildered ­ The NIHAA Update welcomes leuers and the law i11 the Breast Implant Case but still beloved." The second Shannon news f rom its readers. We wish to provide (Norton, 1996). She has written many Lecture was presented in October 1998 news about NIH to its alumni and to report influential articles and editorials, and by Dr. Leon Rosenberg and published i.n alumni concerns and i11for111ation--appoi111­ is the co-author of lhe textbook Basic both Science, 283:331-332, Physician­ 111ems, honors, publications and other Pathology. Scien1i sts-Endangered and Essential," interesting developmems-to theircolleag11es. you have news abo111 yo11rself or other She is a member of the Institute of and the Journal of Clinical lnvestiga­ If alumni or co111111e11tsls 11ggestio11s for tire Medicine of the National Academy of rion, 103:1621-1626, "The Physician­ NTHAA Update. please drop a note to the Sciences, the American College of scientist: An essential- and fragile­ editor. We reserve the right to edit materials. Physicians, and the Association of link in the medical research chain." American Physicians. In 1997, Angell Last year's lecture was by Dr. Purnell Editor: Harriet R. Greenwald was named by Time magazine as one of W. Choppin, retired president of the NIHAA Newsletter Edilorial Advisory the 25 most influential Americans. Howard Hughes Med.i cal Institute, who Committee The article cited her not only for her spoke on, "A Role for Private Support work at the Journal, but also for her of Biomedical Research." Jerome G. Green, Chairman book Science on Trial, which became Please see invitation to the lecture by Artric e Bader an "instant classic on junk science." Angell below. Michael M. Goflesman Victoria A. Harden Carl Leventhal Robert G. Martin TIDS ISYOURINVITATIONTOTBESHANNON LECTURE Abner Louis Noiklns Saul Rosen The N1H Alumni Association Stonn Whaley corclially invites you to attend the fourth Richard G. Wya 11 JamesA.SbannonLecture NIHAA Newsletter Board of Contrib11ting Editors "The Ethics of Clinical Trials" P. Eliuibeth Anderson Linda Brown Dr. Marcia Angell Giorgio Bernardi H. Franklin Bwm Former Editor-in-Chief, Henryk Eisenberg The New England Journal ofMedicine Donald S. Fredrickson Lars A. Hanson George Klein Wednesday, Feb. 14, 2001 at 3 p.m. Riclwrd M. Krcmse Masur Auditorium, Bldg. 10 Richard McManus Carlos Monge Reception to Follow Roger Monier Michael Sela 2 SUMMER 2 0 0 0 NI HAA Officers Research Festival 'DO Slated for Oct. 1D·13 William 1. Gay. President By Paula Cohen Murray Goldstein, Vice Preside111 (For details, see box on this page and Jerome O. Green, Vice President Preparations are well under way for sidebar on p. 4). Storm Whaley, Secretwy!Treasurer the '14'hannual Nil-1 Research Festival The NIH Job Fair for postdoctural Past Presidents to be held on the Bethesda campus fellows, sponsored by the Foundation William S. Jordan, .fr., 1997-1999 Oct. 10- 13. The festival organizing for the NIH and spearheaded by the Calvi11 8. Bt1ldwin, Jr., 1995-1997 committee, co-chaired this year by NIH Office of Education 's acting Thomas J. Kennedy. Jr., 1993-1995 NHLBJ scientific directors Dr. Robert director Brenda Hanning and fair Joe R. Held, 1991- 1993 Balaban and Dr. Elizabeth Nabel, has Gordon D. Wallace, 1990-1991 coordinator Shirley Forehand, will kick been busy planning a wide-ranging off research festival events on Tuesday, Board of Directors program showcasing the scientific Oct. I0. A keynote address on "Career Alexander Adler diversity of the NIH intramural research Decision Strategies in the Era of Aririce V. Bader program. This year's festival will Biotech: How to Decide What Pathway W. Emmen Barkley follow a format similar to that of last Edwi11 Becker ls Right for You," by Dr. Wtlliam Robert l. Berger year's festival, comprised of plenary, Schrader, Ligand Pharmaceuticals, will Rita Colwell mini-symposia, and poster sessions; a begin job fair acrivities ar 9:00 a.m. in Pe1erC011dliffe job fair for postdoctoral fellows; a Jack Masur Auditorium, CC. The job Cyrus R. Creveling biomedfoal research equipment show: fair will follow in the NIH Visicor Murray Eden special exhibits on intramural re­ Carl Frells Infonnation Center, CC, and will host a Pe1er /.,. Frommer sources; and a lunchtime food fair. number of representatives from Samuel W. Greenhouse Samuel S. Herman Mini-Symposia I Wednesday, October 11 2:00-4:00 p.m. .lane SundelofJones • Mechanisms ofBlood Pressure ReguWJ.ion and DysregulaJjon Joseph Keyes, Jr. Irwin Kopin Co-Chairs: Mark Knepper, Nm...Bl, and Juergen Schnermann, NIDDK Lloyd W. /.,a IV • Erulocannabinoids and Related lipid Mediators Carl Levemhal Co-Chairs: George Kunos. NIAAA, and Miles Herkenbam, NIMH Waller Magruder • Acquired Mitochondrial Toxicities KQfh/een McCormick Chair: Marinos Dalakas, NINDS Caroly11 McHale James 0 'Don11ell • DNA Polymerases, Helicases, Nucleases, and Genomic (in)Stability Paul D. Parkman Co-Chairs: Vilbelm Bohr, NIA, and Roger Woodgate, NICHD Joseph Perpich • Tile Cell Cyclt! Karl Piez Co-Chairs: Mary Lilly, NICHD, and Oroa Cohen-Fix. NIDDK Harley Sheffield • Development and Degeneration of Glial Cells /.,a.wre11ce E. Shulman Joan Topalian Co-Chairs: Vittorio Gallo, NICHD, and Lynne Hudson, NINDS Paul Van Nevel Mini-Symposia II Thursday, October 12 2.·30-4.·30p.m. NIRAA Staff • Chromatin Structure, Gene Regulati.on and Boundary Elements Harrie/ R. Greenwald Chair: David Clark, NIDDK Mary Calley Hartman • Protein Analyses and Proteomics: Emerging Methods in Mass Spectrometry Chair: Sanford Markey. NlMH Tim NIH ALUMNI A ssocJK rJONTHANKS'fu.£ • Membrane Microdomains FouNDATION FOR rn1> NIH, MERCK & Co., [ NC., AND WYETH·A YERST R ESEA RCH OF Co-Chairs: Teresa Jones.
Recommended publications
  • 2004 Albert B. Sabin Gold Medal Address Delivered by Award Recipient William S
    2004 Albert B. Sabin Gold Medal Address Delivered by Award Recipient William S. Jordan, Jr., M.D. With a Tribute by John R. LaMontagne, Ph.D. May 25, 2004 Arlington, Virginia INTRODUCTION by H.R. Shepherd, D.Sc. Chairman, The Albert B. Sabin Vaccine Institute he Sabin Vaccine Institute pursues Dr. Albert B. Sabin’s vision of a T world protected from disease by vaccines. The annual awarding of the Sabin Gold Medal has always been among our most meaningful traditions. The 2004 award was presented in May to an icon in vaccine research, William S. Jordan, Jr., M.D., at a ceremony in Arlington, Virginia, during the 7th Annual Conference on Vaccine Research, co-organized by the Sabin Vaccine Institute. The positive impact of vaccines on the health and well being of humanity continues to be a marvel of our modern world. Vaccine improvements, new vaccines, and vaccines in the pipeline represent an advancing field of science that brings untold preventive benefit to millions around the world. Along with his career in vaccine research, Dr. Jordan has engaged in compiling the record of scientific advancements in the field. His name is synonymous with both vaccine research and the compendium—The Jordan Report—that for 25 years has been a repository for advances in the vaccine field. The Sabin Gold Medal Advisory Committee, chaired by Maj. Gen. Philip K. Russell, M.D. (USA Ret.), selected Dr. Jordan for this honor after canvassing 300 members of the scientific community. We are pleased to recognize Dr. Jordan with this honor, noting his exemplary contributions in the vaccine field and commitment to lifesaving medical discoveries.
    [Show full text]
  • November 3, 1998, NIH Record, Vol. L, No. 22
    R E C 0 R Still The Second Best Thing About Payday Budding Young Scientists Aim HI H.t: 1 G H Life, Death and Everything in Between For the Stars Research Festival 12 a Big Draw By Kimberly C. Mitchell Ever heard a 10-year-old kid describe the Research Festival t was as if some giant had grabbed the NIH campus by the mechanics of jet propulsion? Or the Packs 'em In corner up near the firehouse on Old Georgetown Rd. and tilted principles behind refracted light? That's Iit so that everything slid helplessly toward the Natcher Bldg. what some Now THAT's a Oct. 6-9 as the twelfth version of Research Festival (originally youngsters Budget! only a daylong event) drew many can do after hundreds of NIH'ers to a ravishing feast spending 6 of intramural science. For a 3-day months in stretch, Natcher and its environs were to Eleven Elevate to science what Bethesda is to restaurants­ the AAAS Fellowhood Adventure a teeming smorgasbord of tasty possibili­ in Science ties. (AIS) It became almost comical, after a day or program. Get Ready for two, to see literally hundreds of pre-, Quality of Work . .... From post- and postpostdocs fleeing the , Life Week Dr. Rebecca Hackett helps a October to crowded morning plenary sessions for student prepare to measure March of one of dozens of workshops held in NASA Administrator the uptake of water and each year, various nooks and warrens within the nutrients through the root Daniel Goldin opens sprawling Natcher complex. All adopted these young session on origins of /ife.
    [Show full text]
  • The Jordan Report 20Th Anniversary: Accelerated Development Of
    USA ES IC V R E S N A M U H & D H H E T P L A A R E T H M F F E N O T Accelerated Development of Vaccines Preface In 1982, the National Institute of Allergy and Infectious Dis­ Along with these technological advances, there has been a eases (NIAID) established the Program for the Accelerated heightened awareness of the importance of vaccines for global Development of Vaccines. For 20 years, this program has helped health and security. Acquired immunodeficiency syndrome stimulate the energy, intellect, and ability of scientists in micro­ (AIDS), malaria, and tuberculosis have demonstrated to the biology, immunology, and infectious diseases. Vaccine research world the importance of public health in economic development. has certainly benefited. The status report reflecting this Most recently, the threat of bioterrorism has reminded many progress in vaccine research has come to be known as the Jor­ Americans of the value of vaccines as public health tools. dan Report in recognition of Dr. William Jordan, past director of NIAID’s Division of Microbiology and Infectious Diseases Articles by outside experts in this edition highlight many of the (DMID) and the program’s earliest advocate. scientific advances, challenges, and issues of vaccine research during these two decades. As we look to the decade ahead, the This anniversary edition of the Jordan Report summarizes 20 payoffs from basic research will continue to invigorate vaccine years of achievements in vaccine research driven by the explo­ development, but economic, risk communication, and safety sive technological advances in genomics, immunology, and challenges are likely to influence the licensing of new vaccines.
    [Show full text]
  • NIH Technology Transfer Efforts
    Kudos to NIH Technology Transfer Efforts Prepared by Office of Technology Transfer | Office of Intramural Research National Institutes of Health U.S. Department of Health & Human Services April 2016 Table of Contents 2016 Federal Laboratory Consortium | National Award | Excellence in Technology Transfer Discovery to Commercialization: New Immunotherapy for Rare Childhood Cancer, Neuroblastoma ........ 1 Development of First Immunotherapy to Treat Chordoma ......................................................................... 2 2015 Federal Laboratory Consortium | Mid-Atlantic Region Award | Excellence in Technology Transfer First FDA Approval: Combination Therapy for Rare Childhood Cancer, Neuroblastoma ............................. 3 Novel Therapeutics to Treat Niemann-Pick C Disease and Other Lysosomal Disorders .............................. 4 Development of First Immunotherapy to Treat Chordoma, a Rare Bone Cancer ........................................ 6 Federal Laboratory Consortium | Mid-Atlantic Region Award | STEM Award NIH International Technology Transfer Mentoring Program........................................................................ 7 National Institutes of Health | Inventors on NIH, CDC, and FDA Patents Issued in FY 2015 Congratulations to Inventors on NIH Patents Issued in FY 2015.................................................................. 9 Congratulations to Inventors on CDC Patents Issued in FY 2015 ............................................................... 14 Congratulations to Inventors on FDA
    [Show full text]
  • Front Matter (PDF)
    CancerResearch AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH December 15, 1998 Volume 58 •Number 24 PP. 5633-5890 ISSN0008-5472 •CNREA 8 AMERICAN ASSOCIATION FOR CANCER RESEARCH 90TH ANNUAL MEETING April 10-14,1999 Pennsylvania Convention Center, Philadelphia, PA SPECIAL EVENTS (Topics with Confirmed Speakers/Organizers in Parentheses) EDUCATIONAL SESSIONS AND METHODS WORK "MEET-THE-EXPERT" SUNRISE SESSIONS SHOPS (SATURDAY AFTERNOON, APRIL 10, 1999) DrugResistance(Susan P. C. Cole) To Be Announced Cancer Screening(Barnett S. Kramer) Molecular Signaling of CML (Jean Y. J. Wang) OFFICIAL OPENING EVENT (SUNDAY MORNING, Apoptosis and Chemotherapy (John A. Hickman) APRIL 11, 1999) Caspases (Nancy A. Thornberry) Presidential Address (Webster K. Cavenee) Molecular Cytogenetics (Joe W. Gray) Plenary Session: New Frontiers in Cancer Research p53 GeneTherapy-mediatedRadio/Chemosensitization(Esther H. Chang) Genetics (Robert A. Weinberg) The Genetics of Multiple Endocrine Neoplasia Type 2 (MEN 2) (Bruce A. J. Immunology and Vaccines (Lloyd J. Old) Ponder) Therapeutics and Translational Research (Judah Folkman) Differentiation Therapy (Samuel Waxman) Hormonal Intervention and Prevention (C. Kent Osborne) AIDS-related Malignancies (Ellen G. Feigal) AACR-Pezcoller International Cancer Research Award Lecture Tumor Vaccine Therapy (Michael T. Lotze) Special Lecture (James D. Watson) Integration of Biological Agents into Radiotherapy (William H. McBride) Molecular Detection of Minimal Residual Disease (Theodore F. Zipf) SYMPOSIA Microsatellite Instability (David Sidransky) Animal Models for Human Cancer: Recent Developments, New Chemoprevention Trials: Science vs. Art vs. Fantasy (David S. Alberts) Challenges (Tyler Jacks) Genetic Imprinting (Andrew P. Feinberg) Advances in Chemoprevention (Raymond N. DuBois) Cancer Metastasis: Cellular and Clinical Studies (David Tarin) Infectious Agents and Cancer (Nancy E.
    [Show full text]
  • The History of Tumor Virology Ronald T
    AACRCentennial Series The History of Tumor Virology Ronald T. Javier and Janet S. Butel Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas Abstract BCE), the Chinese Rites of the Zhou Dynasty (1100–400 BCE), and Ramayana In the century since its inception, the field of tumor virology the ancient Indian manuscript (500 BCE). In ancient has provided groundbreaking insights into the causes of Egypt, intellectual power was primarily restricted to priests who human cancer. Peyton Rous founded this scientific field in claimed to be direct recipients of divine knowledge, so it is not 1911 by discovering an avian virus that induced tumors in surprising that writings of the time attributed the etiology of chickens; however, it took 40years for the scientific diseases such as cancer to the ‘‘will of Gods’’ (1, 2). community to comprehend the effect of this seminal finding. The ancient Greek civilization, on the other hand, is credited Later identification of mammalian tumor viruses in the 1930s with freeing medicine from the bonds of religion (2–4). Rather than by Richard Shope and John Bittner, and in the 1950s by accepting religious dogma, Hippocrates (460–370 BCE) used Ludwik Gross, sparked the first intense interest in tumor systematic observation and logical thinking to propose the virology by suggesting the possibility of a similar causal role humoral theory of cancer. Based on teachings by the Greek for viruses in human cancers. This change in attitude opened philosopher Empedocles who believed that air, water, earth, and the door in the 1960s and 1970s for the discovery of the first fire were the four cardinal elements of the universe, Hippocrates human tumor viruses—EBV, hepatitis B virus, and the theorized that the human body contains a mixture of the four papillomaviruses.
    [Show full text]
  • Harold E. Varmus
    RETROVIRUSES AND ONCOGENES I Nobel Lecture, December 8, 1989 by HAROLD E. VARMUS Departments of Microbiology and Immunology, and Biochemistry and Biophysics, University of California at San Francisco, San Francisco, U.S.A. INTRODUCTION The story that Mike Bishop and I will tell in these two lectures is one in which retroviruses, oncogenes, our personal histories, and the history of tumor virology are closely interwoven. It begins with some simple questions about the origin and behavior of viral genes and takes us to a vantage point from which we can survey many aspects of retroviruses and animal cells, including some of the aberrations that lead to cancer. We now know that retroviruses capture normal cellular genes and convert them to cancer- causing genes, called oncogenes. Such transductions are rare, but depend upon the normal events of an intricate virus life cycle. Retroviruses have introduced us to more than forty cellular genes with the potential to become oncogenes, some discovered as components of viral genomes, others as genetic targets for viral insertion mutations. It has been our privilege to participate in a generous share of the experiments that established these principles. But we have required the help of many talented people in our laboratories at UCSF, as well as the collaboration and friendly competition of others elsewhere. (I mention as many names as the narrative can bear, but inevitably I must apologize to valued colleagues who remain anonymous here.) Several viruses also figure in our tale, but Rous sarcoma virus again has the leading role, yet another of many tributes to the pioneering work of Peyton Rous and to the principle of delayed gratification in science.
    [Show full text]
  • U.S. Department of Health and Human Services National Institutes of Health
    U.S. Department of Health and Human Services National Institutes of Health Minutes of the Fifth Joint Meeting of the National Advisory Council on Alcohol Abuse and Alcoholism, National Advisory Council on Drug Abuse, and National Cancer Advisory Board May 3, 2017 Rockville, Maryland Members of the National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA), National Advisory Council on Drug Abuse (NIDA), and the National Cancer Advisory Board of the National Cancer Institute (NCI) convened for their fifth joint meeting on May 3, 2017, in Rockville, Maryland. Chaired by Dr. George Koob, Director of NIAAA, and Dr. Nora Volkow, Director of NIDA, this open session convened at 9:03 a.m. National Advisory Council on Alcohol Abuse and Alcoholism Members Present: Carmen E. Albizu-Garcia, M.D. Louis E. Baxter, Sr., M.D Daniel J. Calac, M.D. Carlo C. DiClemente, Ph.D. Tom Donaldson Alex M. Dopico, M.D., Ph.D. James H. Eberwine, Ph.D. Paul J. Kenny, Ph.D. (by telephone) Joe L. Martinez, Ph.D. Adolf Pfefferbaum, M.D. Arun J. Sanyal, M.D. Vijay H. Shah, M.D. Rajita Sinha, Ph.D. Susan M. Smith, Ph.D. Constance M. Weisner, D.R.P.H. National Advisory Council on Drug Abuse Members Present: Judith D. Auerbach, Ph.D. Julie A. Blendy, Ph.D. John Carnevale, Ph.D. Linda Chang, M.D. H. Westley Clark, M.D. Arthur T. Dean Karl Deisseroth, M.D., Ph.D. (by telephone) Marie Gallo Dyak Kenneth P. Mackie, M.D. Lisa A. Marsch, Ph.D. Edward V. Nunes, M.D.
    [Show full text]
  • Oral History Center University of California the Bancroft Library Berkeley, California
    Oral History Center, The Bancroft Library, University of California Berkeley Oral History Center University of California The Bancroft Library Berkeley, California J. Michael Bishop Scientist, UCSF Chancellor, and Nobel Laureate Interviews conducted by Sally Smith Hughes in 2016 and 2017 Copyright © 2017 by The Regents of the University of California Oral History Center, The Bancroft Library, University of California Berkeley ii Since 1954 the Oral History Center of the Bancroft Library, formerly the Regional Oral History Office, has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the nation. Oral History is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well-informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is bound with photographs and illustrative materials and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ********************************* All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and J. Michael Bishop dated June 22, 2017. The manuscript is thereby made available for research purposes.
    [Show full text]
  • Medlineplus Winter 2015
    Trusted Health Information from the National Institutes of Health NIHMedlineWINTER 2015 Plusthe magazine When the heart is not in rhythm Game show host and comedian Howie Mandel speaks out about atrial fibrillation (AFib)—a condition he knows firsthand. AFibMore than 2.5 million adults have atrial fibrillation (AFib), the most common form of heart arrhythmia in the United States. Alzheimer's Disease Research Searching the Web for Health Tips for Healthy Aging And Caregiving Advice Info You Can Trust It's easier now than ever before to make lifestyle Learn the latest research about the disease Always start with MedlinePlus, the gold standard changes that can add years to your life—and life to your years. and tips for effective caregiving. from the National Library of Medicine. A publication of the NATIONAL INSTITUTES OF HEALTH and the FRIENDS of the NATIONAL LIBRARY OF MEDICINE MLPWinter15.indd 1 12/12/14 12:07 PM FRIENDS OF THE NATIONAL LIBRARY OF MEDICINE National Library of Medicine Welcomes 500 Students to “Science Pathfinders” Event at the National Institutes of Health What does 3-D printing have to do with health and med- icine? How do forensic scientists use DNA to genetically “fingerprint” and identify crime and disaster victims? How can a high school science student start a career at the National Institutes of Health? The answers to these and other questions were revealed at a lively all-day event, “Science Pathfinders at NLM/NIH,” September 26, 2014, on the NIH campus in Bethesda, Maryland. The VIP guests were more than 500 middle and high school students at public and private schools in Maryland and the District of Columbia, who heard presentations from top scientists and medical doctors on the latest advances in medical research.
    [Show full text]
  • Robert J. Huebner, M.D.: a Virologists Odyssey
    Robert J. Huebner, M.D.: A Virologist’s Odyssey Edward A. Beeman, M.D., F.A.C.P. 2005 This text was prepared for the Office of NIH History at the National Institutes of Health under Contract No. 263—MD - 010289 Beeman, Robert J. Huebner, M.D.: A Virologist’s Odyssey, 2005. 1 Table of Contents Acknowledgments 4 Introduction 11 Chapter 1: The Early Years 17 Chapter 2: Rickettsialpox 39 Chapter 3: Q Fever in Southern California 55 Chapter 4: Coxsackie Viruses—Herpangina 89 Chapter 5: Coxsackie Viruses—Epidemic Pleurodynia 119 Chapter 6: Exploring Respiratory Viruses and Adenoviruses 135 Chapter 7: The Junior Village Era 162 Chapter 8: The New Viruses 186 Chapter 9: Volunteer and Vaccine Studies 205 Chapter 10: Seventy New Viruses; Summation; Transition 235 Chapter 11: The Lieutenants 240 Chapter 12: Polyoma Virus—Explorations in Oncology 281 Chapter 13: Domestic Life; Life on the Farm 303 Chapter 14: The Tumor (T) Antigens 320 Chapter 15: Collaboration with the National Cancer Institute 340 Chapter 16: Hybrids, Helper Viruses, Adenovirus Testing, Field Studies 368 Chapter 17: The Oncogene Theory of Huebner and Todaro: Reverse Transcriptase 388 Chapter 18: Politics and Cancer 414 Beeman, Robert J. Huebner, M.D.: A Virologist’s Odyssey, 2005. 2 Chapter 19: Critics Anonymous, Contracts versus Grants, The Zinder Report 443 Chapter 20: Personnel Relationships, Additional Activities of the Viral Carcinogenesis Branch and the Virus Cancer Program 465 Chapter 21: The Oncogene Unveiled 488 Chapter 22: A Second Beginning, Illness and Decline 499 Chapter 23: Legacy 510 Chapter 24: Treading Water in the Secretarial Pool, Other Random Observations 523 Appendices: Appendix A: Curriculum Vitae 542 Appendix B: Robert J.
    [Show full text]
  • J. Michael Bishop
    RETROVIRUSES AND ONCOGENES II Nobel Lecture, December 8, 1989 by J. M ICHAEL B I S H O P Department of Microbiology and Immunology, Department of Bio- chemistry and Biophysics, and The G. W. Hooper Research Foundation, University of California at San Francisco, San Francisco, U.S.A. I am grateful to the family in whose embrace I formed my aspirations; the institutions modest and grand that helped me nurture those aspirations; the many colleagues with whom I have shared the pursuit of nature’s secrets; the Nobel Foundation and the Karolinska Institute for glorious hospitality; and Swedish Medicine, which restored my larynx to some semblance of function. The English critic Cyril Connolly once remarked that: “The true index of a man’s character is the health of his wife.” My life in science has been rich and rewarding. I have sacrified very little. But my partner in that life has sacrified a great deal: Kathryn, my wife of thirty years. I take this moment to speak my gratitude for her forbearance, and to acknowledge that matters are not likely to improve. If I were asked to choose a biographical theme for today, it would have to be procrastination. Peyton Rous withdrew from medical school for a year to spend time on a ranch in Texas, ostensibly to recover from tuberculosis (1). Once back in medicine, he found himself “unfit to be a real doctor” (in his own words) and turned to Pathology for an entry into research. Harold Varmus dallied with English Literature before entering medical school, as you have heard (2).
    [Show full text]